Treatment of neurodegenerative diseases using adult bone marrow stromal cell-derived neurons

Expert Opinion on Biological Therapy

Volumn 5, Issue 4, 2005, Pages 427-435

  Dezawa, Mari ^a   Hoshino, Mikio ^a,b   Ide, Chizuka ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Action potential; Axonal regeneration; Bone marrow; Dopaminergic neuron; Mesenchymal cell; Parkinsons disease; Schwann cell; Stroke; Transdifferentiation; Transplantation

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; FORSKOLIN; NERVE GROWTH FACTOR; NOTCH RECEPTOR; SCATTER FACTOR; TACROLIMUS; VASCULOTROPIN;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; BONE MARROW CELL; BONE MARROW STROMAL CELL; BRAIN ISCHEMIA; CELL TRANSPLANTATION; DEGENERATIVE DISEASE; ETHICS; GENE TRANSFER; HUMAN; HUMAN CELL; MITOSIS; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PROTEIN DOMAIN; RAT; REVIEW; RISK BENEFIT ANALYSIS; STROMA CELL; TREATMENT OUTCOME;

ADULT; ANIMALS; BONE MARROW CELLS; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS; STROMAL CELLS;

ANIMALIA;

EID: 17844385835     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.5.4.427     Document Type: Review

References (47)

1. KAWASAKI H, MIZUSEKI K, NISHIKAWA S et al.: Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron (2000) 28:31-40. Dopaminergic neurons were induced from ES cells.
2. SUGAYA K: Potential use of stem cells in neuroreplacement therapies for neurodegenerative diseases: Int. Rev. Cytol. (2003) 228:1-30. An important review about stem cells in neurodegenerative disease.
3. OHTA M, SUZUKI Y, NODA T et al.: Implantation of neural stem cells via cerebrospinal fluid into the injured root. Neuroreport (2004) 15:1249-1253.
4. LANG KJ, RATHJEN J, VASSILIEVA S, RATHJEN PD: Differentiation of embryonic stem cells to a neural fate: a route to re-building the nervous system? J. Neurosci. Res. (2004) 76:184-192.
5. MARKAKIS EA, PALMER TD, RANDOLPH-MOORE L, RAKIC P, GAGE FH: Novel neuronal phenotypes from neural progenitor cells. J. Neurosci. (2004) 24:2886-2897.
6. KUHN HG, WINKLER J, KEMPERMANN G, THAL LJ, GAGE FH: Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J. Neurosci. (1997) 17:5820-5829.
7. PROCKOP DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science (1997) 276:71-74.
8. CHOPP M, ZHANG XH, LI Y et al.: Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport (2000) 11:3001-3005.
9. HOFSTETTER CP, SCHWARZ EJ, HESS D et al.: Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. USA (2002) 99:2199-2204.
10. OHTA M, SUZUKI Y, NODA T et al.: Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp. Neurol. (2004) 187:266-278.
11. BORLONGAN CV, LIND JG, DILLON-CARTER O et al.: Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res. (2004) 1010:108-116.
12. CHOPP M, LI Y: Treatment of neural injury with marrow stromal cells. Lancet Neurol. (2002) 1:92-100.
13. HAYNESWORTH SE, BABER MA, CAPLAN AI: Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J. Cell. Physiol. (1996) 166:585-592.
14. DORMADY SP, BASHAYAN O, DOUGHERTY R, ZHANG XM, BASCH RS: Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment. J. Hematother. Stem Cell Res. (2001) 10:125-140.
15. DAVID ROODMAN G: Role of stromal-derived cytokines and growth factors in bone metastasis. Cancer (2003) 97:733-738.
16. CHEN X, KATAKOWSKI M, LI Y et al.: Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J. Neurosci. Res. (2002) 69:687-691.
17. MAHMOOD A, LU D, WANG L, CHOPP M: Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. J. Neurotrauma (2002) 19:1609-1617.
18. SANCHEZ-RAMOS J, SONG S, CARDOZO-PELAEZ F et al.: Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol. (2000) 164:247-256. One of the earlier studies to induce neuronal cells from MSCs.
19. WOODBURY D, SCHWARZ EJ, PROCKOP DJ, BLACK IB: Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. (2000) 61:364-370. One of the earlier studies to induce neuronal cells from MSCs.
20. JIANG Y, JAHAGIRDAR BN, REINHARDT RL et al.: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature (2002) 418:41-49.
21. DEZAWA M, TAKAHASHI I, ESAKI M, TAKANO M, SAWADA H: Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur. J. Neurosci. (2001) 14:1771-1776. Specific induction of Schwann cells from MSCs.
22. MIMURA T, DEZAWA M, KANNO H, SAWADA H, YAMAMOTO I: Peripheral nerve regeneration by transplantation of bone marrow stromal cell-derived Schwann cells in adult rats. J. Neurosurg. (2004) 101:806-812. Functional recovery in peripheral nervous system injury using MSC-derived Schwann cells.
23. DEZAWA M, KANNO H, HOSHINO M et al.: Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest. (2004) 113:1701-1710. The most important paper in this review; describes the method to induce neuronal cells from MSCs with the highest efficiency
24. WEINMASTER G, ROBERTS VJ, LEMKE G: A homolog of Drosophila Notch expressed during mammalian development. Development (1991) 113:199-205.
25. NYE JS, KOPAN R, AXEL R: An activated Notch suppresses neurogenesis and myogenesis but not gliogenesis in mammalian cells. Development (1994) 120:2421-2430.
26. LUNDKVIST J, LENDAHL U: Notch and the birth of glial cells. Trends Neurosci. (2001) 24:492-494.
27. YAMAMOTO N, YAMAMOTO S, INAGAKI F et al.: Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor. J. Biol. Chem. (2001) 276:45031-45040.
28. YAMASAKI M, YAMADA K, FURUYA S et al.: 3-Phosphoglycerate dehydrogenase, a key enzyme for 1-serine biosynthesis, is preferentially expressed in the radial glia/astrocyte lineage and olfactory ensheathing glia in the mouse brain. J. Neurosci. (2001) 21:7691-7704.
29. SHIBATA T, YAMADA K, WATANABE M et al.: Glutamate transporter GLAST is expressed in the radial glia-astrocyte lineage of developing mouse spinal cord. J. Neurosci. (1997) 17:9212-9219.
30. VICARIO-ABEJON C, COLLIN C, MCKAY RD, SEGAL M: Neurotrophins induce formation of functional excitatory and inhibitory synapses between cultured hippocampal neurons. J. Neurosci. (1998) 18:7256-7271.
31. MORRISON SJ, PEREZ SE, QIAO Z et al.: Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell (2000) 101:499-510.
32. SUN Y, NADAL-VICENS M, MISONO S et al.: Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell (2001) 104:365-376.
33. ISHIBASHI M, MORIYOSHI K, SASAI Y et al.: Persistent expression of helix-loop-helix factor HES-1 prevents mammalian neural differentiation in the central nervous system. EMBO J. (1994) 13:1799-1805.
34. ZHENG JL, SHOU J, GUILLEMOT F, KAGEYAMA R, GAO WQ: Hes1 is a negative regulator of inner ear hair cell differentiation. Development (2000) 127:4551-4560.
35. SEIDEL HM, LAMB P, ROSEN J: Pharmaceutical intervention in the JAK/STAT signaling pathway. Oncogene (2000) 19:2645-2656.
36. NAKASHIMA K, TAKIZAWA T, OCHIAI W et al.: BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc. Natl. Acad. Sci. USA (2001) 98:5868-5873.
37. KUROOKA H, KURODA K, HONJO T: Roles of the ankyrin repeats and C-terminal region of the mouse notch1 intracellular region. Nucleic Acids Res. (1998) 26:5448-5455.
38. FRANKLIN JL, BERECHID BE, CUTTING FB et al.: Autonomous and non-autonomous regulation of mammalian neurite development by Notch1 and Delta1. Curr. Biol. (1999) 9:1448-1457.
39. NEUFELD B, GROSSE-WILDE A, HOFFMEYER A et al.: Serine/Threonine kinases 3pK and MAPK-activated protein kinase 2 interact with the basic helix-loop-helix transcription factor E47 and repress its transcriptional activity. J. Biol. Chem. (2000) 275:20239-20242.
40. STORK PJ, SCHMITT JM: Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. (2002) 12:258-266.
41. IHARA S, NAKAJIMA K, FUKADA T et al.: Dual control of neurite outgrowth by STAT3 and MAP kinase in PC12 cells stimulated with interleukin-6. EMBO J. (1997) 16:5345-5352.
42. LONGA EZ, WEINSTEIN PR, CARLSON S, CUMMINS R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke (1989) 20:84-91.
43. AKERUD P, ALBERCH J, EKETJALL S, WAGNER J, ARENAS E: Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons. J. Neurochem. (1999) 73:70-78.
44. SAKURADA K, OHSHIMA-SAKURADA M, PALMER TD, GAGE FH: Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development (1999) 126:4017-4026.
45. YAMADA H, DEZAWA M, SHIMAZU S et al.: Transfer of the von Hippel-Lindau gene to neuronal progenitor cells in treatment for Parkinson's disease. Ann. Neurol. (2003) 54:352-359.
46. OLSSON M, NIKKHAH G, BENTLAGE C, BJORKLUND A: Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. (1995) 15:3863-3875.
47. MONTOYA CP, CAMPBELL-HOPE LJ, PEMBERTON KD, DUNNETT SB: The 'staircase test': a measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Methods (1991) 36:219-228.